TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 11, 2025 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the release of its sixth annual 2025 Industry Trends Survey. This year’s report explores how public safety professionals
Strategic partnership delivers future-proof, global payments capabilities for insurance carriers BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) — Duck Creek Technologies, the global intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, today announced a strategic partnership with Worldpay®, a global industry leader in payments technology
Slovenian Nova Gorica and Italian Gorizia are coming together to write a new cultural chapter – one without borders. On 8 February 2025, Slovenia’s Cultural Holiday, the twin cities are hosting a spectacular all-day opening celebration. Under the title From Station to Station, the festivities will unfold across streets and
La ville slovène de Nova Gorica et la ville italienne de Gorizia s’unissent pour écrire un nouveau chapitre culturel qui transcende les frontières. Les villes jumelles transfrontalières organisent une célébration d’ouverture spectaculaire qui durera toute la journée du 8 février 2025, journée de la culture en Slovénie. Sous le titre
PERTH, Australia, Feb. 08, 2025 (GLOBE NEWSWIRE) — Australian Gold Reagents’ (AGR) Board has made a final investment decision to proceed with the expansion of its sodium cyanide production facility in Kwinana, Western Australia, positioning AGR as one of the world’s largest sodium cyanide producers for the gold mining industry.
Slovenian Nova Gorica and Italian Gorizia are coming together to write a new cultural chapter – one without borders. On 8 February 2025, Slovenia’s Cultural Holiday, the twin cities are hosting a spectacular all-day opening celebration. Under the title From Station to Station, the festivities will unfold across streets and
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 06, 2025 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the general availability of Generative Artificial Intelligence (GenAI) capabilities within Guardian, the Company’s SaaS-based evidence management solution. By
– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in third quarter 2025- -Topline results from pivotal Phase 3 Trial in Immunoglobulin G4-Related Disease (INDIGO) expected year-end
Promoting revolutionary values and uniting movements for South Africa’s economic freedom.
Enter your email address below to subscribe to my newsletter
